Raymond James lowered the firm’s price target on Integer (ITGR) to $95 from $143 and keeps an Outperform rating on the shares after the stock tumbled 32% on news of headwinds from three customers limiting 2026 organic growth to LSD. The update came as a surprise to investors who were already skittish into the print, which actually saw reasonably solid Q3 results, the firm says. Sensitivity to customer confidentiality limits clarity, and Raymond thinks has further hindered the stock. While frustrating, the firm believes the breadth of exposures, as well as new launches to come in 2026 and beyond, enable that recovery beginning late 2026.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ITGR:
